CancerIQ
Hospitals and Health CareIllinois, United States11-50 Employees
CancerIQ provides a platform that enables clinicians to use genetic information to identify patients at elevated cancer risk and to integrate genetic evaluation into care at the point of service. The aim is to enable tailored cancer prevention plans and to help healthcare systems anticipate and manage this costly and emotionally devastating disease. The company is based in Chicago, Illinois, and operates with a small to mid-sized team. Within the Hospitals and Health Care sector, CancerIQ positions itself with an end-to-end approach to precision cancer prevention, early detection, and treatment. In June 2026, the company announced the integration of Rhythm Biosciences' geneType Cancer Risk Assessment into its platform, expanding the risk-assessment tools available within clinicians' existing workflows. Its user base includes clinicians and health system leaders seeking to embed genetic risk evaluation into routine care.
1-888-653-2347 
support@leadiq.com 
